ALPRAZOLAM
BENZODIAZEPINES·ANXIETY·+3
GREENSTONE-MYLA
Indication
Anxiety with depression
Anxiety with depression describes a psychiatric presentation affecting the central nervous system in which core features of a depressive episode coincide with clinically significant anxiety symptoms or co-occurring anxiety disorders. Read more about Anxiety with depression
218 drugs 105 manufacturers
Drugs that treat it
Common Anxiety with depression therapies.
VENLAFAXINE HCL ER (venlafaxine HCl)
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+4
GREENSTONE-MYLA
VENLAFAXINE HCL ER (venlafaxine HCl)
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+4
ST MARYS MPP
XANAX (alprazolam)
BENZODIAZEPINES·ANXIETY·+3
VIATRIS SPECIAL
ALPRAZOLAM ODT (alprazolam)
BENZODIAZEPINES·ANXIETY·+3
DIRECT RX
VENLAFAXINE HCL ER (venlafaxine HCl)
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+4
GSK Consumer Healthcare
ESCITALOPRAM OXALATE
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+2
ALMATICA PHARMA
ALPRAZOLAM
BENZODIAZEPINES·ANXIETY·+3
AVPAK
DULOXETINE HCL
ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
REMEDYREPACK, I
Filter & compare in the drug finder →Opens the drug finder with Anxiety with depression preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAnxiety with depression describes a psychiatric presentation affecting the central nervous system in which core features of a depressive episode coincide with clinically significant anxiety symptoms or co-occurring anxiety disorders.
Affecting adolescents and adults, this clinical state is characterized by persistent dysphoria, pervasive sadness, and loss of interest or pleasure, coupled with prominent tension, autonomic hyperarousal, excessive apprehension, restlessness, and impaired concentration.
Pathophysiologically, it involves dysregulation of monoaminergic neurotransmitter networks—specifically serotonin, norepinephrine, and dopamine—alongside heightened hypothalamic-pituitary-adrenal axis reactivity and altered corticolimbic circuitry, which typically correlates with greater symptom severity, chronic impairment, and elevated suicide risk compared to uncomplicated depression.
- nih.gov
Anxiety with depression describes a psychiatric presentation affecting the central nervous system in which core features of a depressive episode coincide with clinically significant anxiety symptoms or co-occurring anxiety disorders Pathophysiologically, it involves dysregulation of monoaminergic neurotransmitter networks—specifically serotonin, norepinephrine, and dopamine—alongside heightened hypothalamic-pituitary-adrenal axis reactivity and altered corticolimbic circuitry, which typically co...
- nih.gov
Anxiety with depression describes a psychiatric presentation affecting the central nervous system in which core features of a depressive episode coincide with clinically significant anxiety symptoms or co-occurring anxiety disorders Pathophysiologically, it involves dysregulation of monoaminergic neurotransmitter networks—specifically serotonin, norepinephrine, and dopamine—alongside heightened hypothalamic-pituitary-adrenal axis reactivity and altered corticolimbic circuitry, which typically co...
- youtube.com
Affecting adolescents and adults, this clinical state is characterized by persistent dysphoria, pervasive sadness, and loss of interest or pleasure, coupled with prominent tension, autonomic hyperarousal, excessive apprehension, restlessness, and impaired concentration
- hightowerclinical.com
Affecting adolescents and adults, this clinical state is characterized by persistent dysphoria, pervasive sadness, and loss of interest or pleasure, coupled with prominent tension, autonomic hyperarousal, excessive apprehension, restlessness, and impaired concentration Pathophysiologically, it involves dysregulation of monoaminergic neurotransmitter networks—specifically serotonin, norepinephrine, and dopamine—alongside heightened hypothalamic-pituitary-adrenal axis reactivity and altered cortic...
- cdc.gov
Affecting adolescents and adults, this clinical state is characterized by persistent dysphoria, pervasive sadness, and loss of interest or pleasure, coupled with prominent tension, autonomic hyperarousal, excessive apprehension, restlessness, and impaired concentration
Personalize your experience
Follow Anxiety with depression and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.